VU0364572 (trifluoroacetate salt) 247egeline whereas the CYM-5520 is an

whereas the CYM-5520 is an agonist with an EC50 of 1

Chemical Name: 5-[(8aR)-octahydropyrrolo[1

8-tetrahydropteridin-6-one

91(20):13080-13087

C[C@@H]1CC[C@]2(O[C@@H]1CC1=NC3=C(C(=CC=C3O1)NC)C([O-])=O)O[C@H]([C@H](C)C(=O)C1=CC=CN1)[C@H](C)C[C@H]2C

VU0364572 (trifluoroacetate salt) 247egeline whereas the CYM-5520 is anIC50: 477 172 nM VU0364572 is a M1 agonist. Alzheimer's disease (AD) is the leading cause of dementia worldwide, and no disease modifying therapy is availables. Selective M1 muscarinic acetylcholine receptor activation is an attractive mechanism for AD therapy since M1 mediates key effects on cognition, memory, and behavior and has potential for disease modifying effects on A formation and tau phosphorylation. In vitro: Previous study found that